Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin B Begg

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
American Journal of Epidemiology|August 28, 2012
Detecting and exploiting etiologic heterogeneity in epidemiologic studiesColin B Begg, Emily C Zabor
Journal of the National Cancer Institute|December 2, 2004
Reflections on the landmark studies of beta-carotene supplementationAnna J Duffield-Lillico, Colin B Begg
Cancer Research Communications|March 27, 2023
Predicting Cancer Risk from Germline Whole-exome Sequencing Data Using a Novel Context-based Variant Aggregation ApproachZoe Guan, Colin B Begg, Ronglai Shen
Biometrics|September 11, 2020
Using the "Hidden" genome to improve classification of cancer typesSaptarshi Chakraborty, Colin B Begg, Ronglai Shen
Statistics in Medicine|July 11, 2013
An assessment of estimation methods for generalized linear mixed models with binary outcomesMarinela Capanu, Mithat Gönen, Colin B Begg
Human Heredity|October 31, 2021
Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant AssociationsZoe Guan, Ronglai Shen, Colin B Begg
Clinical Trials (London, England)|July 12, 2020
Editorial: Clinical trial design in the era of COVID-19Colin B Begg, Mithat Gonen, Daniel F Heitjan
The Annals of Applied Statistics|November 24, 2015
USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESSIrina Ostrovnaya, Venkatraman E Seshan, Colin B Begg
Clinical Trials (London, England)|September 6, 2014
"Right to Try" lawsColin B Begg, KyungMann Kim, James D Neaton
JAMA|December 9, 2004
Resurrecting treatment histories of dead patients: a study design that should be laid to restPeter B Bach, Deborah Schrag, Colin B Begg
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
American Journal of Epidemiology|August 28, 2012
Detecting and exploiting etiologic heterogeneity in epidemiologic studiesColin B Begg, Emily C Zabor
Journal of the National Cancer Institute|December 2, 2004
Reflections on the landmark studies of beta-carotene supplementationAnna J Duffield-Lillico, Colin B Begg
Cancer Research Communications|March 27, 2023
Predicting Cancer Risk from Germline Whole-exome Sequencing Data Using a Novel Context-based Variant Aggregation ApproachZoe Guan, Colin B Begg, Ronglai Shen
Biometrics|September 11, 2020
Using the "Hidden" genome to improve classification of cancer typesSaptarshi Chakraborty, Colin B Begg, Ronglai Shen
Statistics in Medicine|July 11, 2013
An assessment of estimation methods for generalized linear mixed models with binary outcomesMarinela Capanu, Mithat Gönen, Colin B Begg
Human Heredity|October 31, 2021
Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant AssociationsZoe Guan, Ronglai Shen, Colin B Begg
Clinical Trials (London, England)|July 12, 2020
Editorial: Clinical trial design in the era of COVID-19Colin B Begg, Mithat Gonen, Daniel F Heitjan
The Annals of Applied Statistics|November 24, 2015
USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESSIrina Ostrovnaya, Venkatraman E Seshan, Colin B Begg
Clinical Trials (London, England)|September 6, 2014
"Right to Try" lawsColin B Begg, KyungMann Kim, James D Neaton
JAMA|December 9, 2004
Resurrecting treatment histories of dead patients: a study design that should be laid to restPeter B Bach, Deborah Schrag, Colin B Begg
Pageof 19